QA: Sarepta Therapeutics Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000873303_2019_Sarepta_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000873303, Sarepta Therapeutics Inc.

  xvar xval
0 AssetsCurrent 1,426,183,000
1 IntangibleAssetsNetIncludingGoodwill 11,574,000
2 PropertyPlantAndEquipmentNet 97,024,000
3 remainder_Assets 107,294,000
4 LiabilitiesCurrent 173,690,000
5 LiabilitiesNoncurrent 15,555,000
6 remainder_Liabilities 420,554,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 207,761,000
9 ResearchAndDevelopmentExpense 401,843,000
10 remainder_Expenses 34,366,000
11 remainder_Revenues 301,034,000
12 remainder_NetIncome -18,982,000
13 remainder_ComprehensiveNetIncome 280,000
  yvar yval
0 Assets 1,642,075,000
1 Liabilities 609,799,000
2 Expenses 643,970,000
3 Revenues 301,034,000
4 StockholdersEquity 1,032,276,000
5 NetIncome -361,918,000
6 ComprehensiveNetIncome -361,778,000
7 BaseVar 1,608,070,000
8 EconomicCapitalRatio 1.26

Edgar->Model Mapping

Feature Distribution

Change over Time